Emergent Biosolutions Inc (EBS) is down -11.04% in a Week, Should You Buy?

A rating of 75 puts Emergent Biosolutions Inc (EBS) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Emergent Biosolutions Inc's score of 75 means it scores higher than 75% of stocks in the industry. Emergent Biosolutions Inc also received an overall rating of 51, putting it above 51% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 108 out of the 148 industries.

EBS has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on EBS!

See Full EBS Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Emergent Biosolutions Inc Stock Today?

Emergent Biosolutions Inc (EBS) stock is up 4.83% while the S&P 500 is down -0.11% as of 2:23 PM on Monday, Mar 11. EBS is higher by $0.13 from the previous closing price of $2.69 on volume of 1,267,353 shares. Over the past year the S&P 500 is higher by 32.74% while EBS is down -70.41%. EBS lost -$14.85 per share the over the last 12 months. Click Here to get the full Stock Report for Emergent Biosolutions Inc stock.